Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wafermine for acute post-operative pain
NCT03246971Phase 2Completed
- Sponsor
- iX Biopharma
- Start
- Aug 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Wafermine in acute pain, sponsored by iX Biopharma. Started Aug 2017; status: completed.
02
Drugs
Wafermine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03246971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03246971.